Biotech startups that raised Series A
Updated 23 Oct 2026
2,368
Companies
$49.4B
Last round total
100
Rows shown
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Estuary Biotherapeutics | Series A | $93.0M | 2026-10-16 | San Francisco | Biotech |
| 2 | Altay Therapeutics | Series A | $37.0M | 2026-10-14 | San Francisco | Biotech |
| 3 | HydRegen | Series A | $8.0M | 2026-10-14 | Oxford | Biotech |
| 4 | Allygen Biologics | Series A | $44.8M | 2026-10-13 | Beijing | Biotech |
| 5 | GenMedicn Biopharma | Series A | 2026-10-07 | Nanjing | Biotech | |
| 6 | arboretum lifesciences | Series A | $30.0M | 2026-10-06 | Boston | Biotech |
| 7 | Sensible Biotechnologies | Series A | $27.0M | 2026-10-06 | Oxford | Artificial intelligence |
| 8 | BioOra | Series A | $16.8M | 2026-10-01 | Wellington | Biotech |
| 9 | CAD Therapeutics | Series A | $4.0M | 2026-10-01 | New York | Biotech |
| 10 | R1 Therapeutics | Series A | $3.0M | 2026-09-30 | London | Biotech |
| 11 | Zymofix | Series A | $2.2M | 2026-09-30 | Wondelgem | Biotech |
| 12 | Breye Therapeutics | Series A | $76.7M | 2026-09-29 | Hørsholm | Biotech |
| 13 | ai3Bio | Series A | $48.0M | 2026-09-29 | Pittsburgh | Biotech |
| 14 | Arkea Bio | Series A | $15.0M | 2026-09-29 | Charlestown | Biotech |
| 15 | Nanomerics | Series A | 2026-09-29 | Harrow | Biotech | |
| 16 | ViferaXS | Series A | $13.7M | 2026-09-23 | Tübingen | Biotech |
| 17 | Ramona | Series A | $25.0M | 2026-09-22 | Durham | Artificial intelligence |
| 18 | Apollon | Series A | $3.7M | 2026-09-22 | Seoul | Artificial intelligence |
| 19 | CellsBin | Series A | 2026-09-22 | New Haven | Biotech | |
| 20 | Biolevate | Series A | $34.4M | 2026-09-21 | Paris | Artificial intelligence |
| 21 | ImpriMed | Series A | $10.0M | 2026-09-18 | Palo Alto | Artificial intelligence |
| 22 | Altis Labs | Series A | $25.0M | 2026-09-17 | Toronto | Artificial intelligence |
| 23 | Matisse Pharmaceuticals | Series A | $16.0M | 2026-09-17 | Geleen | Biotech |
| 24 | Connexus Therapeutics | Series A | $5.0M | 2026-09-17 | Hong Kong | Biotech |
| 25 | Robigo | Series A | 2026-09-17 | Cambridge | Biotech | |
| 26 | Anew Labs | Series A | $290.0M | 2026-09-16 | Shanghai | Artificial intelligence |
| 27 | Evia Bio | Series A | $5.5M | 2026-09-16 | Minneapolis | Biotech |
| 28 | RegCell | Series A | $44.0M | 2026-09-15 | Emeryville | Biotech |
| 29 | Mithrl | Series A | $20.0M | 2026-09-15 | San Francisco | Artificial intelligence |
| 30 | Nix | Series A | $10.0M | 2026-09-15 | Boston | Artificial intelligence |
| 31 | Elehear | Series A | $1.5M | 2026-09-10 | Seattle | Artificial intelligence |
| 32 | Solstice Oncology | Series A | $225.0M | 2026-09-09 | Boston | Biotech |
| 33 | TwoStep Therapeutics | Series A | $62.5M | 2026-09-09 | Palo Alto | Biotech |
| 34 | Tectora Therapeutics | Series A | $55.0M | 2026-09-09 | New York | Biotech |
| 35 | Caspian Therapeutics | Series A | $50.0M | 2026-09-09 | San Diego | Biotech |
| 36 | N&E Innovations | Series A | $1.7M | 2026-09-09 | Singapore | Biotech |
| 37 | BrainChild Bio | Series A | $116.0M | 2026-09-08 | Seattle | Biotech |
| 38 | Vaxdyn | Series A | $12.8M | 2026-09-07 | Sevilla | Biotech |
| 39 | Anivance AI Corporation | Series A | $6.3M | 2026-09-07 | Hsinchu | Artificial intelligence |
| 40 | SiccaNova Therapeutics | Series A | $7.9M | 2026-09-03 | Tsukuba | Biotech |
| 41 | Typewriter Therapeutics | Series A | $56.3M | 2026-09-02 | Cambridge | Biotech |
| 42 | DataHow | Series A | 2026-09-02 | Zürich | Biotech | |
| 43 | Amyl Therapeutics | Series A | $9.6M | 2026-09-01 | Liège | Biotech |
| 44 | EIT Pharma | Series A | $35.0M | 2026-08-31 | Kirkland | Biotech |
| 45 | Xianyan Biopharma | Series A | $21.8M | 2026-08-31 | Chengdu | Biotech |
| 46 | ABLE Labs | Series A | $8.8M | 2026-08-31 | Incheon | Biotech |
| 47 | Marvel Stone Healthcare | Series A | 2026-08-28 | Wuxi Shi | Biotech | |
| 48 | Hepo Biotechnology | Series A | 2026-08-28 | Shanghai | Biotech | |
| 49 | Adaptyv Biosystems | Series A | $40.0M | 2026-08-25 | Lausanne | Artificial intelligence |
| 50 | TECLens | Series A | $10.0M | 2026-08-25 | Stamford | Biotech |
| 51 | Anda Biopharma | Series A | 2026-08-24 | Shenzhen | Artificial intelligence | |
| 52 | Fibrolink Biotech | Series A | $1.5M | 2026-08-21 | Guangzhou | Biotech |
| 53 | SiranBio | Series A | $59.5M | 2026-08-20 | Suzhou | Biotech |
| 54 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 55 | KaliVir Immunotherapeutics | Series A | $14.0M | 2026-08-19 | Pittsburgh | Biotech |
| 56 | Leal Therapeutics | Series A | $30.0M | 2026-08-17 | Worcester | Biotech |
| 57 | Enginprime Medical | Series A | $12.0M | 2026-08-17 | Hangzhou | Biotech |
| 58 | Errui Xinyue | Series A | $14.3M | 2026-08-13 | Daxing | Biotech |
| 59 | Remepy | Series A | $36.0M | 2026-08-12 | Ramat Gan | Artificial intelligence |
| 60 | Paterna Biosciences | Series A | $6.3M | 2026-08-12 | Salt Lake City | Biotech |
| 61 | Infinimmune | Series A | $75.0M | 2026-08-11 | Alameda | Artificial intelligence |
| 62 | Omega Ophthalmics | Series A | $7.0M | 2026-08-11 | Lexington | Biotech |
| 63 | Remedium Bio | Series A | $10.0M | 2026-08-10 | Needham | Biotech |
| 64 | ClonOrgan | Series A | 2026-08-07 | Chengdu | Biotech | |
| 65 | Integrated Biosciences | Series A | $68.4M | 2026-08-05 | Redwood City | Artificial intelligence |
| 66 | Phil Rivers Technology | Series A | $29.6M | 2026-08-05 | Beijing | Artificial intelligence |
| 67 | Dash Bio | Series A | $30.0M | 2026-08-03 | Boston | Artificial intelligence |
| 68 | Protoga | Series A | $14.8M | 2026-08-03 | Shenzhen | Biotech |
| 69 | Algen Biotechnologies | Series A | $12.5M | 2026-08-03 | San Francisco | Artificial intelligence |
| 70 | GLADIO | Series A | $658K | 2026-08-01 | Taichung | Biotech |
| 71 | Beyond Therapeutics | Series A | $29.6M | 2026-07-30 | Shanghai | Biotech |
| 72 | Yuantian Bio | Series A | $14.8M | 2026-07-30 | Tianjin | Biotech |
| 73 | Genta Kyushu Bio | Series A | $14.8M | 2026-07-30 | Beijing | Biotech |
| 74 | Trace Biosciences | Series A | $8.3M | 2026-07-29 | Beaverton | Biotech |
| 75 | CORE Biomedicine | Series A | $21.0M | 2026-07-28 | Allston | Biotech |
| 76 | GOLGENIA | Series A | $1.7M | 2026-07-28 | Milan | Biotech |
| 77 | NewLine | Series A | $14.8M | 2026-07-27 | Weifang | Biotech |
| 78 | Elio Labs | Series A | $21.0M | 2026-07-23 | San Mateo | Artificial intelligence |
| 79 | Cooler Heads | Series A | $3.3M | 2026-07-23 | San Diego | Biotech |
| 80 | Transcripta Bio | Series A | $24.0M | 2026-07-22 | Palo Alto | Biotech |
| 81 | Yuannang Bio | Series A | $14.0M | 2026-07-22 | Hangzhou | Biotech |
| 82 | Tikva Allocell | Series A | $8.0M | 2026-07-22 | Singapore | Biotech |
| 83 | Fibrox | Series A | $3.7M | 2026-07-21 | Pudong | Biotech |
| 84 | Brenus Pharma | Series A | $12.6M | 2026-07-20 | Issoire | Biotech |
| 85 | Deepin Technology | Series A | $14.1M | 2026-07-14 | Haidian | Artificial intelligence |
| 86 | Tianhu Technology | Series A | $29.0M | 2026-07-13 | Minhang | Artificial intelligence |
| 87 | ArcGen Bioscience | Series A | $6.7M | 2026-07-13 | Daejeon | Biotech |
| 88 | MingCeler | Series A | 2026-07-13 | Guangzhou | Biotech | |
| 89 | e-BLOT Life Sciences | Series A | 2026-07-13 | Pudong | Biotech | |
| 90 | Shenzhen Bay Island Cell Technology | Series A | $20.6M | 2026-07-10 | Biotech | |
| 91 | AlgaleX | Series A | $2.2M | 2026-07-10 | Uruma | Biotech |
| 92 | Alchemab Therapeutics | Series A | $33.6M | 2026-07-09 | London | Biotech |
| 93 | SynMetaBio | Series A | $14.7M | 2026-07-06 | Shanghai | Biotech |
| 94 | Insaifeiying | Series A | 2026-07-06 | Suzhou | Biotech | |
| 95 | Telum Therapeutics | Series A | $20.5M | 2026-07-01 | Noáin | Biotech |
| 96 | ZymeCO | Series A | $4.0M | 2026-07-01 | Monument | Biotech |
| 97 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 98 | Xellar Biosystems | Series A | $29.5M | 2026-06-30 | Newton | Artificial intelligence |
| 99 | Prime Lifescience | Series A | $14.7M | 2026-06-30 | Hangzhou | Biotech |
| 100 | Lingtai Krypton Biotechnology | Series A | $13.7M | 2026-06-26 | Shuangliu | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,368.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Altos Labs | Series A | $3.0B | 2021-09-06 | San Francisco | Biotech |
| 2 | Xaira Therapeutics | Series A | $1.0B | 2024-04-23 | South San Francisco | Artificial intelligence |
| 3 | Verdiva Bio | Series A | $411.0M | 2025-01-09 | London | Biotech |
| 4 | LianBio | Series A | $310.0M | 2020-10-29 | Shanghai | Biotech |
| 5 | Uniquity Bio | Series A | $300.0M | 2024-05-15 | Malvern | Biotech |
| 6 | ReNAgade Therapeutics | Series A | $300.0M | 2023-05-23 | Cambridge | Biotech |
| 7 | Anew Labs | Series A | $290.0M | 2026-09-16 | Shanghai | Artificial intelligence |
| 8 | Mabwell Biotech | Series A | $278.5M | 2020-04-29 | Shanghai | Biotech |
| 9 | Orbital Therapeutics | Series A | $270.0M | 2023-04-26 | Cambridge | Biotech |
| 10 | NantOmics | Series A | $250.8M | 2015-06-01 | Culver City | Biotech |
| 11 | Anthos Therapeutics | Series A | $250.0M | 2019-02-27 | Cambridge | Biotech |
| 12 | Aiolos Bio | Series A | $245.0M | 2023-10-24 | San Francisco | Biotech |
| 13 | Adrestia Therapeutics | Series A | $232.6M | 2020-12-18 | Babraham | Biotech |
| 14 | Solstice Oncology | Series A | $225.0M | 2026-09-09 | Boston | Biotech |
| 15 | BlueRock Therapeutics | Series A | $225.0M | 2016-12-12 | Toronto | Biotech |
| 16 | Dispatch Bio | Series A | $216.0M | 2025-07-23 | Philadelphia | Biotech |
| 17 | Tome Biosciences | Series A | $213.0M | 2023-12-12 | Watertown | Biotech |
| 18 | AirNexis Therapeutics | Series A | $200.0M | 2026-01-09 | Palo Alto | Biotech |
| 19 | Treeline Biosciences | Series A | $200.0M | 2025-09-03 | Watertown | Biotech |
| 20 | Tenvie Therapeutics | Series A | $200.0M | 2025-01-08 | Brisbane | Biotech |
| 21 | Esco Lifesciences | Series A | $200.0M | 2021-05-26 | Singapore | Biotech |
| 22 | Alveus Therapeutics | Series A | $197.0M | 2026-01-08 | Philadelphia | Biotech |
| 23 | Callio Therapeutics | Series A | $187.0M | 2025-03-03 | Seattle | Biotech |
| 24 | Braveheart Bio | Series A | $185.0M | 2025-11-05 | San Francisco | Biotech |
| 25 | cAMPfield Therapeutics | Series A | $180.0M | 2026-05-20 | San Diego | Biotech |
| 26 | Timberlyne Therapeutics | Series A | $180.0M | 2025-01-09 | San Diego | Biotech |
| 27 | Antares Therapeutics | Series A | $177.0M | 2025-05-15 | Boston | Biotech |
| 28 | Allist Pharmaceuticals | Series A | $173.9M | 2019-05-24 | Shanghai | Biotech |
| 29 | GentiBio | Series A | $157.0M | 2021-08-11 | Seattle | Biotech |
| 30 | Clasp Therapeutics | Series A | $150.0M | 2024-03-20 | Cambridge | Biotech |
| 31 | MasterControl | Series A | $150.0M | 2022-12-15 | Salt Lake City | Biotech |
| 32 | Curon Biopharma | Series A | $150.0M | 2018-07-30 | Shanghai | Biotech |
| 33 | Bitterroot Bio | Series A | $145.0M | 2023-06-07 | Palo Alto | Biotech |
| 34 | Doma Biopharmaceutical | Series A | $142.1M | 2022-06-01 | Suzhou | Biotech |
| 35 | Yufunian | Series A | $141.4M | 2023-05-29 | Dali | Biotech |
| 36 | Ottimo Pharma | Series A | $140.0M | 2024-12-19 | Sandwich | Biotech |
| 37 | VectorY | Series A | $138.0M | 2023-11-13 | Amsterdam | Biotech |
| 38 | Serapha Bio | Series A | $138.0M | 2026-01-01 | New York | Biotech |
| 39 | Reunion Neuroscience | Series A | $133.0M | 2025-09-16 | Toronto | Biotech |
| 40 | Slate Medicines | Series A | $130.0M | 2026-02-24 | Raleigh | Biotech |
| 41 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 42 | Coultreon Biopharma | Series A | $125.0M | 2026-04-28 | Heverlee | Biotech |
| 43 | Ambros Therapeutics | Series A | $125.0M | 2025-12-16 | Irvine | Biotech |
| 44 | Adcytherix | Series A | $122.8M | 2025-10-16 | Marseille | Biotech |
| 45 | NGM Biopharmaceuticals | Series A | $122.0M | 2024-07-17 | South San Francisco | Biotech |
| 46 | Merida Biosciences | Series A | $121.0M | 2025-04-08 | Cambridge | Biotech |
| 47 | Solve Therapeutics | Series A | $120.0M | 2025-11-17 | Belmont | Biotech |
| 48 | Ouro Medicines | Series A | $120.0M | 2025-01-10 | San Francisco | Biotech |
| 49 | Cellular Biomedicine Group | Series A | $120.0M | 2021-09-28 | Palo Alto | Biotech |
| 50 | BrainChild Bio | Series A | $116.0M | 2026-09-08 | Seattle | Biotech |
| 51 | Myricx Bio | Series A | $115.3M | 2024-07-08 | London | Biotech |
| 52 | Axonis Therapeutics | Series A | $115.0M | 2024-10-30 | Boston | Biotech |
| 53 | RQ Bio | Series A | $112.5M | 2026-06-24 | London | Biotech |
| 54 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 55 | Syncromune | Series A | $111.8M | 2024-12-20 | Fort Lauderdale | Biotech |
| 56 | Zephyr AI | Series A | $111.0M | 2024-03-13 | Fairfax Station | Artificial intelligence |
| 57 | RayThera | Series A | $110.0M | 2025-04-04 | San Diego | Biotech |
| 58 | Neogene Therapeutics | Series A | $110.0M | 2020-09-14 | Amsterdam | Biotech |
| 59 | Sidera Bio | Series A | $109.0M | 2025-12-09 | Copenhagen | Biotech |
| 60 | AavantiBio | Series A | $107.0M | 2020-10-22 | Cambridge | Biotech |
| 61 | Tortugas Neuroscience | Series A | $106.0M | 2026-04-21 | Framingham | Biotech |
| 62 | Synnovation Therapeutics | Series A | $102.0M | 2023-12-14 | Wilmington | Biotech |
| 63 | NILO Therapeutics | Series A | $101.0M | 2025-10-08 | New York | Biotech |
| 64 | Trace Neuroscience | Series A | $101.0M | 2024-11-12 | South San Francisco | Biotech |
| 65 | Stipple Bio | Series A | $100.0M | 2026-04-06 | Cambridge | Biotech |
| 66 | Addition Therapeutics | Series A | $100.0M | 2025-12-17 | South San Francisco | Biotech |
| 67 | Nudge | Series A | $100.0M | 2025-07-22 | San Francisco | Biotech |
| 68 | OTR Therapeutics | Series A | $100.0M | 2025-06-01 | Shanghai | Biotech |
| 69 | OnCusp Therapeutics | Series A | $100.0M | 2024-01-04 | New York | Biotech |
| 70 | Inceptive | Series A | $100.0M | 2023-09-07 | Palo Alto | Biotech |
| 71 | Paratus Sciences | Series A | $100.0M | 2023-02-27 | New York | Biotech |
| 72 | Reistone Biopharma | Series A | $100.0M | 2022-05-09 | Pudong | Biotech |
| 73 | Tichuang Biotechnology | Series A | $100.0M | 2022-03-14 | Guangzhou | Biotech |
| 74 | Rectify Pharmaceuticals | Series A | $100.0M | 2021-10-14 | Cambridge | Biotech |
| 75 | Dyno Therapeutics | Series A | $100.0M | 2021-05-06 | Cambridge | Artificial intelligence |
| 76 | Joyn Bio | Series A | $100.0M | 2017-09-14 | Boston | Biotech |
| 77 | Emergence Therapeutics | Series A | $98.1M | 2021-12-07 | Duisburg | Biotech |
| 78 | NanoPhoria | Series A | $97.8M | 2025-10-06 | Milan | Biotech |
| 79 | Cajal Neuroscience | Series A | $96.0M | 2022-11-29 | Seattle | Biotech |
| 80 | Trogenix | Series A | $94.1M | 2025-10-06 | Edinburgh | Biotech |
| 81 | Firefly Bio | Series A | $94.0M | 2024-02-15 | San Francisco | Biotech |
| 82 | Newleos Therapeutics | Series A | $93.5M | 2025-02-13 | Boston | Biotech |
| 83 | Estuary Biotherapeutics | Series A | $93.0M | 2026-10-16 | San Francisco | Biotech |
| 84 | Memento Medicines | Series A | $93.0M | 2026-06-18 | Chester | Biotech |
| 85 | Kivu Bioscience | Series A | $92.0M | 2024-10-28 | San Mateo | Biotech |
| 86 | Bambusa Therapeutics | Series A | $90.0M | 2025-11-17 | Boston | Biotech |
| 87 | Nested Therapeutics | Series A | $90.0M | 2022-10-06 | Cambridge | Biotech |
| 88 | Turing Pharmaceuticals | Series A | $90.0M | 2015-08-10 | New York | Biotech |
| 89 | Mnemo Therapeutics | Series A | $90.0M | 2021-06-16 | Paris | Biotech |
| 90 | Immutrin | Series A | $87.1M | 2026-03-24 | Cambridge | Biotech |
| 91 | Clade Therapeutics | Series A | $87.0M | 2021-11-03 | Cambridge | Biotech |
| 92 | MoleculeMind | Series A | $86.0M | 2026-06-17 | Haidian | Artificial intelligence |
| 93 | Rhygaze | Series A | $86.0M | 2025-01-10 | Basel | Biotech |
| 94 | Bioleum | Series A | $85.0M | 2025-05-22 | Oklahoma City | Biotech |
| 95 | Stylus Medicine | Series A | $85.0M | 2025-05-12 | Cambridge | Biotech |
| 96 | Rampart Bioscience | Series A | $85.0M | 2023-10-24 | La Jolla | Biotech |
| 97 | Epirium Bio | Series A | $85.0M | 2019-12-18 | San Diego | Biotech |
| 98 | Averna Therapeutics | Series A | $85.0M | 2024-06-25 | Boston | Biotech |
| 99 | Fosun Kite Biotechnology | Series A | $84.2M | 2025-10-17 | Shanghai | Biotech |
| 100 | Antag Therapeutics | Series A | $84.1M | 2024-12-04 | Copenhagen | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,368.
By month
| Month | Companies |
|---|---|
| 2024-11 | 24 |
| 2024-12 | 30 |
| 2025-01 | 31 |
| 2025-02 | 16 |
| 2025-03 | 18 |
| 2025-04 | 13 |
| 2025-05 | 17 |
| 2025-06 | 24 |
| 2025-07 | 20 |
| 2025-08 | 22 |
| 2025-09 | 31 |
| 2025-10 | 29 |
| 2025-11 | 32 |
| 2025-12 | 43 |
| 2026-01 | 44 |
| 2026-02 | 19 |
| 2026-03 | 26 |
| 2026-04 | 19 |
| 2026-05 | 25 |
| 2026-06 | 26 |
| 2026-07 | 26 |
| 2026-08 | 27 |
| 2026-09 | 34 |
| 2026-10 | 9 |
Table 3. Biotech startups that raised Series A by month of the round. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,368.
Country
| Country | Companies |
|---|---|
| United States | 1,059 |
| China | 484 |
| United Kingdom | 126 |
| South Korea | 83 |
| France | 76 |
| Germany | 58 |
| Switzerland | 55 |
| Canada | 42 |
| Israel | 42 |
| Japan | 41 |
| The Netherlands | 30 |
| Singapore | 25 |
| Belgium | 24 |
| Denmark | 22 |
| Australia | 17 |
Table 4. Biotech startups that raised Series A by country. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,368.
City
| City | Companies |
|---|---|
| Cambridge | 89 |
| San Francisco | 76 |
| Shanghai | 76 |
| New York | 67 |
| San Diego | 61 |
| Boston | 58 |
| London | 44 |
| Hangzhou | 37 |
| Beijing | 34 |
| Palo Alto | 34 |
| Shenzhen | 34 |
| Suzhou | 32 |
| Paris | 31 |
| Seoul | 30 |
| Nanjing | 24 |
Table 5. Biotech startups that raised Series A by city. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,368.
Sector
| Sector | Companies |
|---|---|
| Biotech | 2,368 |
| Health care | 1,918 |
| Software | 283 |
| Artificial intelligence | 171 |
| Hardware | 87 |
| Cybersecurity | 24 |
| Energy | 19 |
| Fintech | 14 |
| Education | 12 |
| Commerce | 10 |
Table 6. Biotech startups that raised Series A by sector. Source: FundingWatcher. Data as of 23 October 2026. Base: 2,368.
Biotech at other stages
Other sectors that raised Series A
software startups that raised Series A13,476
health care startups that raised Series A5,293
AI startups that raised Series A4,099
fintech startups that raised Series A3,591
commerce startups that raised Series A3,642
hardware startups that raised Series A4,443
education startups that raised Series A1,269
cybersecurity startups that raised Series A1,155
energy startups that raised Series A1,029
Cite: FundingWatcher, 2,368 biotech companies whose most recent round is Series A, 23 October 2026. https://fundingwatcher.com/startups/biotech/series-a/